GAEU Consulting’s Client receives € 2.1 million

Clinical Laserthermia System AB receives € 2.1 million within Horizon 2020 dedicated SME Instrument to perform clinical validation of the Interstitial Laser Thermo Therapy (imILTCLS), a polyclinical, heat-induced cancer immunotherapy for gentle and effective treatment of solid tumours. The grant will cover 100 % of the project costs. GAEU wrote the application.

Tomasz Wąsik, CEO Horizon 2020 Centre of Excellence:

– This is yet another grant secured from Horizon 2020 by GAEU Horizon 2020 Centre of Excellence Team. Our competence and expertise in applying for funding for the most advanced and knowledge-intensive R&D projects in Europe continues to grow. The key to success in Horizon 2020 is the combination of the top-notch innovation with strong market focus. Horizon 2020 is the Champions League for SMEs. With the help of GAEU experts, our
Clients stand a real chance of joining this elite group.

Lars-Erik Eriksson, CEO Clinical Laserthermia Systems AB (publ)

- We are very pleased to be granted Horizon 2020 funding. This significant amount of money will be spent on the validation of imILTCLS. The studies will be performed in collaboration with hospitals we have an established relationship with: in Marseille, France, in Porto, Portugal, and in Nottingham, the UK. The grant gives us stronger resources to bring imILTCLS to the market and to offer our method as an option in cancer treatment.

More information:

Tomasz Wąsik, CEO Horizon 2020 Centre of Excellence
Telephone +48 696 108 683,
Lars-Erik Eriksson, CEO Clinical Laserthermia Systems AB (publ)
Tel: +46 (0)702 – 90 33 00,

Pictures for publication to be downloaded from Pressroom:

Download press release





Roland Vilhelmsson


+46 8 556 063 50


Tomasz Wąsik


+48 696 108 683


[calendar id="1359"]